Synthetic Biology Market set to gain considerable impetus by 2025

February 20, 2020


According to the latest research report titled, “Synthetic Biology Market Size By Products (Core Products, Enabling Products, Enabled Products), By Technology (Nucleotide Synthesis & Sequencing, Bioinformatics, Microfluidics, Genetic Engineering), By Application (Pharmaceuticals & Diagnostic, Chemicals, R&D, Agriculture, Energy), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, Switzerland, France, Italy, Spain, Russia, Sweden, China, India, Japan, South Korea, Australia, Malaysia, Taiwan, Indonesia, Singapore, Brazil, Mexico, Argentina, Chile, Saudi Arabia, UAE, South Africa, Egypt), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025,” recently included in the expanding repository of MarketStudyReport.com, synthetic biology market is expected to garner significant revenues over 2019 – 2025.

According to the report, prevailing energy crisis and depletion of fossil fuels have accentuated the demand for biofuels, thereby spurring synthetic biology market share. Burgeoning urbanization and proliferation witnessed in industries, including healthcare, agriculture, industrial chemicals are anticipated to create palpable growth opportunities for stakeholders vying to boost their value propositions in the next half-a-decade. Further, global push to curb carbon footprints, along with furthering the use of renewable energy has augured well for the stakeholders.

Based on products, core products segment is anticipated to expand at a stellar CAGR of over 25% through 2025. Profound use of core products in genes, synthetic organisms and DNA parts for manufacturing pharmaceutical and diagnostic products has triggered demand among end-users. Besides, technology advancements and reduced cost of DNA synthesis have further solidified the position of core products in synthetic biology space.

In terms of technology, microfluids will continue to boost the synthetic biology market share given the fact that the segment recorded more than 20% market share in 2018.

With respect to applications, agriculture sector is touted to be one of the major recipients of synthetic biology. To put things in perspective, compulsion of boosting the crop yield amidst limited and infected arable-land has reinforced the position of synthetic biology in agriculture sector. Notably, the demand for genetically modified transgenic crops is set to observe an uptick against the backdrop of favorable government policies and soaring demand for food. Synthetic biology market from agriculture application is anticipated to witness a CAGR of over 24 percent up to 2025.

Geographical landscape indicates Europe to be a happy hunting ground as there has been an upsurge in R&D activities in clinical research and palpable presence of a battery of pharmaceuticals companies in the region. Some of the factors such as strong demand for bio-based products and prevalence of chronic diseases are perceived to fuel the industry size expansion. Europe synthetic biology market is slated to surpass US$ 18 billion by 2025.

Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/2144020/

Prominent industry players delineated in the report are Thermo Fischer Scientific, DNA2.0, TeselaGenSyntrox Inc, and Blue Hero among others. In a bid to boost the product line, these companies are anticipated to infuse investments in R&D activities, while chances of strategic mergers & acquisitions are highly likely in the ensuing period.


Frequently Asked Questions (FAQ) :

According to the report, prevailing energy crisis and depletion of fossil fuels have accentuated the demand for biofuels, thereby spurring synthetic biology market growth. Burgeoning urbanization and proliferation witnessed in industries, including healthcare, agriculture, industrial chemicals are anticipated to create palpable growth opportunities for stakeholders vying to boost their value proposition in the next half-a-decade. Further, global push to curb carbon footprints and further the use of renewable energy has augured well for the stakeholders.
Core products segment is anticipated to expand at a stellar CAGR of over 25% through 2025. Profound use of core products in genes, synthetic organisms and DNA parts for manufacturing pharmaceutical and diagnostic products has triggered demand among end-users. Besides, technology advancements and reduced cost of DNA synthesis have further solidified the position of core products in synthetic biology space.
Microfluids will continue to boost the synthetic biology market share given the fact that the segment recorded more than 20% market share in 2018. The demand from pharmaceutical and clinical research institutes is projected to bolster synthetic biology market revenue by 2025.
Geographical landscape indicates Europe to a happy hunting ground as there has been an upsurge in R&D activities in clinical research and palpable presence of a battery of pharmaceuticals companies in the region. Some of the factors such as strong demand for bio-based products and prevalence of chronic diseases are perceived to fuel the industry size expansion. Europe synthetic biology market is slated to surpass US$ 18 billion by 2025.
Prominent industry players delineated in the report are Thermo Fischer Scientific, DNA2.0, TeselaGenSyntrox Inc, and Blue Hero among others. In a bid to boost the product line, these companies are anticipated to infuse investments in R&D activities, while chances of strategic mergers & acquisitions are highly likely in the ensuing period.